Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery
EVAR-P
1 other identifier
interventional
30
1 country
1
Brief Summary
Use of endovascular techniques - implantation of a peripheral stent graft and a peripheral flexible stent to isolate the sac of the popliteal artery aneurysm from the circulation and subsequent topical application of a thrombolytic (rtPA) to restore patency of the lower leg blood stream - will lead to a comparable or better outcome in treatment of patients with the popliteal artery aneurysm and acute critical limb ischaemia, compared to currently prevailing use of surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 31, 2017
CompletedFirst Posted
Study publicly available on registry
February 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedFebruary 2, 2017
January 1, 2017
2 years
January 31, 2017
January 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Limb salvage in 12 months
Limba salvage in 12 months
12 Months
Patency of the popliteal artery in 12 months
Patency of the popliteal artery in 12 months
12 Months
Study Arms (2)
Combined endovascular approach
EXPERIMENTALCombined endovascular approach using covered stent and flexible stent in the popliteal artery
Standard optimal therapy (OPT)
EXPERIMENTALstandard therapy of popliteal artery aneurysm using thrombolysis and surgery
Interventions
1. puncture of SFA in orthograde position if possible 2. DSA through 4F dilator, proof of occlusion 3. wire test 4. Heparin 70-80 IU/kg i.a. 5. implantation of peripheral stent graft VIABAHN 6. implantation of peripheral stent SUPERA into stent graft 7. insertion of strait flush catheter for local thrombolysis 8. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTT 1,5-2x) according to the department standards 9. control angiography in 12 hrs or earlier according to clinical status and symptoms 10. repeated angiography in 24 hrs
1. puncture of SFA in orthograde position if possible 2. DSA through 4F dilator, proof of occlusion 3. wire test 4. Unfractionated heparin 70-80 IU/kg i.a. 5. insertion of strait flush catheter for local thrombolysis 6. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTTT 1,5-2x) 7. control angiography in 12 hrs or according to clinical status and symptoms 8. repeated angiography in24 hrs 9. Final result review, vascular team consultation and indication for surgical or conservative management of popliteal artery aneurysm.
Eligibility Criteria
You may qualify if:
- Signed informed consent form for the patient's participation in the study.
- Acute critical limb ischaemia with impairment of the extremity at stage I, IIa, IIb according to SVS classification.
- A popliteal artery aneurysm, confirmed by ultrasound scanning, which on catheterization examination meets the criteria for isolation of the aneurysm sac by implantation of a peripheral stent graft, supported by insertion of a peripheral flexible stent.
- Absence of any contraindication for local thrombolytic therapy.
- An anatomic finding through angiographic investigation that is suitable for endovascular therapy.
You may not qualify if:
- Active bleeding or contraindication for local thrombolysis.
- Life expectance \< 1 yr
- Relevant stenotic defects of valves.
- Myocardial infarction or unstable angina pectoris in past 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charles University, Czech Republiclead
- Petr Varejkacollaborator
Study Sites (1)
Charles University in Prague
Prague, 12808, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.prof. MD, Ph.D.
Study Record Dates
First Submitted
January 31, 2017
First Posted
February 2, 2017
Study Start
August 1, 2016
Primary Completion
August 1, 2018
Study Completion
August 1, 2020
Last Updated
February 2, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share